Copyright
©The Author(s) 2020.
World J Gastrointest Pharmacol Ther. Jun 9, 2020; 11(2): 8-16
Published online Jun 9, 2020. doi: 10.4292/wjgpt.v11.i2.8
Published online Jun 9, 2020. doi: 10.4292/wjgpt.v11.i2.8
Underlying cause | Treatment | |
Benign | ||
Peptic ulcer disease | PPI ± HPE (1st option) | EBD or surgery (2nd option) |
Crohn disease | Corticosteroid (1st option) | EBD or surgery (2nd option) |
Caustic ingestion | EBD or surgery | |
Bouveret syndrome | Surgery or endoscopic removal | |
Large gastric polyp | Endoscopic resection | |
Malignant | ||
Palliative | Endoscopic stent (covered or uncovered) | |
EUS-guided gastroenterostomy | ||
Surgical resection, surgical bypass (gastrojejunostomy) | ||
Radiation therapy | ||
Curative | Surgery | |
Chemotherapy (for lymphoma) |
- Citation: Jeong SJ, Lee J. Management of gastric outlet obstruction: Focusing on endoscopic approach. World J Gastrointest Pharmacol Ther 2020; 11(2): 8-16
- URL: https://www.wjgnet.com/2150-5349/full/v11/i2/8.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v11.i2.8